TPP1 Gene Ceroid Lipofuscinosis Neuronal Type 2 NGS Genetic DNA Test

Introduction

The TPP1 Gene Ceroid Lipofuscinosis Neuronal Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with Ceroid Lipofuscinosis Neuronal Type 2 (CLN2), a rare metabolic disorder. This test utilizes Next Generation Sequencing (NGS) technology to provide accurate and comprehensive genetic analysis, making it an invaluable resource for both patients and healthcare providers.

What the Test Measures

This genetic test specifically measures mutations in the TPP1 gene, which plays a crucial role in cellular metabolism. By analyzing the DNA from a blood sample or extracted DNA, the test can detect specific genetic changes that may lead to the development of CLN2.

Who Should Consider This Test?

Individuals exhibiting symptoms of Ceroid Lipofuscinosis Neuronal Type 2, such as:

• Progressive loss of vision
• Seizures
• Motor skill decline
• Cognitive impairment

Additionally, those with a family history of metabolic disorders or CLN2 should consider this test for early diagnosis and management.

Benefits of Taking the Test

Taking the TPP1 Gene Ceroid Lipofuscinosis Neuronal Type 2 NGS Genetic DNA Test offers several benefits, including:

• Accurate diagnosis of CLN2, enabling timely intervention and treatment.
• Informed family planning through genetic counseling.
• Access to specialized care and support for affected individuals.

Understanding Your Results

Results from the TPP1 Gene test will be provided within 3 to 4 weeks. A healthcare professional will help interpret the findings, guiding patients on the next steps based on their genetic profile.

Test Pricing

Get Tested Today!

We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. We also offer a convenient home sample collection service. To book your TPP1 Gene Ceroid Lipofuscinosis Neuronal Type 2 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.